BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15891195)

  • 21. Neurodevelopmental consequences of pediatric cancer and its treatment: applying an early adversity framework to understanding cognitive, behavioral, and emotional outcomes.
    Marusak HA; Iadipaolo AS; Harper FW; Elrahal F; Taub JW; Goldberg E; Rabinak CA
    Neuropsychol Rev; 2018 Jun; 28(2):123-175. PubMed ID: 29270773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methotrexate-induced leukoencephalopathy presenting as stroke in the emergency department.
    Cruz-Carreras MT; Chaftari P; Shamsnia A; Guha-Thakurta N; Gonzalez C
    Clin Case Rep; 2017 Oct; 5(10):1644-1648. PubMed ID: 29026563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary Intracranial Tumors Following Radiotherapy for Pituitary Adenomas: A Systematic Review.
    Yamanaka R; Abe E; Sato T; Hayano A; Takashima Y
    Cancers (Basel); 2017 Aug; 9(8):. PubMed ID: 28786923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell Transplantation.
    Cordelli DM; Masetti R; Zama D; Toni F; Castelli I; Ricci E; Franzoni E; Pession A
    Front Pediatr; 2017; 5():105. PubMed ID: 28555178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain structure, working memory and response inhibition in childhood leukemia survivors.
    van der Plas E; Schachar RJ; Hitzler J; Crosbie J; Guger SL; Spiegler BJ; Ito S; Nieman BJ
    Brain Behav; 2017 Feb; 7(2):e00621. PubMed ID: 28239531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurocognitive outcomes among children who experienced seizures during treatment for acute lymphoblastic leukemia.
    Nassar SL; Conklin HM; Zhou Y; Ashford JM; Reddick WE; Glass JO; Laningham FH; Jeha S; Cheng C; Pui CH
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28130818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term brain structural magnetic resonance imaging and cognitive functioning in children treated for acute lymphoblastic leukemia with high-dose methotrexate chemotherapy alone or combined with CNS radiotherapy at reduced total dose to 12 Gy.
    Zając-Spychała O; Pawlak MA; Karmelita-Katulska K; Pilarczyk J; Derwich K; Wachowiak J
    Neuroradiology; 2017 Feb; 59(2):147-156. PubMed ID: 28074235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance imaging patterns of treatment-related toxicity in the pediatric brain: an update and review of the literature.
    Rossi Espagnet MC; Pasquini L; Napolitano A; Cacchione A; Mastronuzzi A; Caruso R; Tomà P; Longo D
    Pediatr Radiol; 2017 May; 47(6):633-648. PubMed ID: 27933410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation-induced gliomas: a comprehensive review and meta-analysis.
    Yamanaka R; Hayano A; Kanayama T
    Neurosurg Rev; 2018 Jul; 41(3):719-731. PubMed ID: 27709409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary glioma following acute lymphocytic leukemia: therapeutic implications.
    Yamanaka R; Hayano A
    Neurosurg Rev; 2017 Oct; 40(4):549-557. PubMed ID: 27159974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain volume and cognitive function in adult survivors of childhood acute lymphoblastic leukemia.
    Edelmann MN; Krull KR
    Transl Pediatr; 2013 Oct; 2(4):143-7. PubMed ID: 26835309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurocognitive Late Effects of Chemotherapy in Survivors of Acute Lymphoblastic Leukemia: Focus on Methotrexate.
    van der Plas E; Nieman BJ; Butcher DT; Hitzler JK; Weksberg R; Ito S; Schachar R
    J Can Acad Child Adolesc Psychiatry; 2015; 24(1):25-32. PubMed ID: 26336377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review.
    Cheung YT; Krull KR
    Neurosci Biobehav Rev; 2015 Jun; 53():108-20. PubMed ID: 25857254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of methotrexate on cerebellar development in infant rats.
    Sugiyama A; Sun J; Ueda K; Furukawa S; Takeuchi T
    J Vet Med Sci; 2015 Jul; 77(7):789-97. PubMed ID: 25754651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase in oxidative stress as measured by cerebrospinal fluid lipid peroxidation during treatment for childhood acute lymphoblastic leukemia.
    Ki Moore IM; Gundy P; Pasvogel A; Montgomery DW; Taylor OA; Koerner KM; McCarthy K; Hockenberry MJ
    J Pediatr Hematol Oncol; 2015 Mar; 37(2):e86-93. PubMed ID: 25222054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diffusion tensor imaging and neurocognition in survivors of childhood acute lymphoblastic leukaemia.
    Edelmann MN; Krull KR; Liu W; Glass JO; Ji Q; Ogg RJ; Sabin ND; Srivastava DK; Robison LL; Hudson MM; Reddick WE
    Brain; 2014 Nov; 137(Pt 11):2973-83. PubMed ID: 25125614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
    Bhojwani D; Sabin ND; Pei D; Yang JJ; Khan RB; Panetta JC; Krull KR; Inaba H; Rubnitz JE; Metzger ML; Howard SC; Ribeiro RC; Cheng C; Reddick WE; Jeha S; Sandlund JT; Evans WE; Pui CH; Relling MV
    J Clin Oncol; 2014 Mar; 32(9):949-59. PubMed ID: 24550419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors that increase the risk for reduced white matter volumes and deficits in attention and learning for survivors of childhood cancers.
    Reddick WE; Taghipour DJ; Glass JO; Ashford J; Xiong X; Wu S; Bonner M; Khan RB; Conklin HM
    Pediatr Blood Cancer; 2014 Jun; 61(6):1074-9. PubMed ID: 24464947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence? A report from the Children's Oncology Group.
    Duffner PK; Armstrong FD; Chen L; Helton KJ; Brecher ML; Bell B; Chauvenet AR
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):8-15. PubMed ID: 24345882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.